Sun Pharma recently completed its acquisition of Ranbaxy. It has also set aside a record $7 billion for further acquisitions. And its not the only one, pharma companies are scouting for suitable targets to expand their product baskets and enter new ... Financial Express, 1 month ago
By Vikas Dandekar & Divya Rajagopal MUMBAI: Teva Pharmaceutical Industries' $40.5-billion purchase of Allergan's generics business may help Indian generic-drug makers acquire products that may be divested as part of the antitrust procedures in the US and fill ...Economic Times, 2 months ago
on your WebpageAdd Widget >Get your members hooked!